全球急性肺損傷治療市場研究報告 - 行業分析、規模、佔有率、成長、趨勢及2023至2030年預測
市場調查報告書
商品編碼
1305238

全球急性肺損傷治療市場研究報告 - 行業分析、規模、佔有率、成長、趨勢及2023至2030年預測

Global Acute Lung Injury Treatment Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

出版日期: | 出版商: Value Market Research | 英文 120 Pages | 商品交期: 最快1-2個工作天內

價格

預計到2030年,全球急性肺損傷治療市場需求將從2022年的62.2億美元增至92.7億美元,2022-2030年復合年成長率為5.12%。

急性肺損傷(ALI)是指肺部嚴重發炎,導致肺部積液和氣體交換受損。急性肺損傷是一種需要立即治療的醫療緊急情況。 ALI的治療旨在控制病情的根本原因,並提供支持性護理以改善肺功能和氧合。 ALI的治療非常複雜,根據病情的嚴重程度和潛在病因,治療方法可能會有所不同。對ALI的密切監測和管理對於改善預後和預防併發症至關重要。

市場動態:

ALI發病率的上升,尤其是重症患者的發病率上升,是ALI治療市場的主要驅動力。 ALI發病率上升的主要原因是人口老齡化、慢性病患病率上升以及住院率升高。技術進步大大改善了ALI的診斷和治療。抗發炎藥物和免疫調節劑等新治療藥物的開發使ALI的治療更有效、更有針對性。世界各國政府和監管機構正投入巨資開發ALI的新療法。醫護人員越來越意識到ALI的潛在風險和後果,從而更早進行診斷和治療。這種意識推動了對ALI治療的需求。對無創通氣技術,如持續氣道正壓和雙水準氣道正壓的需求正在增加。與可能導致感染和肺損傷等併發症的有創機械通氣相比,這些技術更受青睞。個性化醫療日益受到重視:個性化醫療在ALI治療市場越來越受歡迎。這種方法是根據患者的基因構成、病史和其他因素為其量身客製化治療方案。個性化醫療有望為ALI帶來更有效、更有針對性的治療。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰了解行業結構,評估全球競爭吸引力。此外,這些工具還對全球急性肺損傷治療市場的各個細分市場進行了全面評估。急性肺損傷治療行業的成長和趨勢為本研究提供了整體方法。

市場細分:

急性肺損傷治療市場報告的這一部分提供了國家和地區層面細分市場的詳細數據,從而幫助戰略家確定各自產品或服務的目標人群以及即將到來的機會。

按療法分類

  • 機械通氣
  • 藥物治療
  • 液體管理
  • 其他

按終端用戶

  • 醫院
  • 專科中心
  • 其他

區域分析

本部分涵蓋了區域前景,突出了北美、歐洲、亞太、拉丁美洲以及中東和非洲地區急性肺損傷治療市場的當前和未來需求。此外,報告還重點介紹了所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的綜合概況以及全球競爭格局的深入分析。急性肺損傷治療市場的主要參與者包括梅奧診所、約翰霍普金斯醫院、克利夫蘭診所、大奧蒙德街醫院、阿波羅醫院、東京醫科大學附屬醫院、查爾斯王子醫院、Helios醫院、Aster醫院等。本節包括競爭格局的整體視圖,其中包括各種戰略發展,如關鍵併購、未來能力、合作夥伴關係、財務概況、合作、新產品開發、新產品上市和其他發展。

目 錄

第一章:前言

  • 報告描述
    • 報告目標
    • 目標受眾
    • 獨特銷售主張(USP)和產品
  • 研究範圍
  • 研究方法
    • 市場調研流程
    • 市場調研方法

第二章:執行摘要

  • 市場亮點
  • 全球市場概況

第三章:急性肺損傷治療-行業分析

  • 簡介- 市場動態
  • 市場驅動因素
  • 市場限制因素
  • 市場機會
  • 行業趨勢
  • 波特五力分析
  • 市場吸引力分析
    • 按療法分類的市場吸引力分析
    • 按終端用戶的市場吸引力分析
    • 市場吸引力分析:按地區

第四章:價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料製造商列表
    • 主要原料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直接行銷
    • 間接行銷
    • 行銷管道發展趨勢

第五章:covid-19爆發的影響分析

第六章:全球急性肺損傷治療市場分析:按療法分類

  • 按療法概述
  • 歷史和預測數據
  • 按療法分析
  • 機械通氣
  • 藥物治療
  • 輸液管理
  • 其他治療

第七章:全球急性肺損傷治療市場分析:按最終用戶分類

  • 終端用戶概述
  • 歷史和預測數據
  • 按最終用戶分析
  • 醫院
  • 專科中心
  • 其他

第8章:全球急性肺損傷治療市場分析:按地區分類

  • 地區前景
  • 產品介紹
  • 北美銷售分析
    • 概述、歷史和預測銷售分析
    • 北美地區銷售分析
    • 北美地區各國銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概述、歷史和預測銷售分析
    • 歐洲銷售分析
    • 歐洲各國銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概述、歷史和預測銷售分析
    • 亞太地區各細分市場銷售分析
    • 亞太地區各國銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳大利亞銷售分析
    • 亞太其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概述、歷史和預測銷售分析
    • 拉丁美洲各細分市場銷售分析
    • 拉丁美洲各國銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概述、歷史和預測銷售分析
    • 中東及非洲地區銷售分析
    • 中東和非洲國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東和非洲其他地區銷售分析

第九章: 急性肺損傷治療企業競爭格局

  • 急性肺損傷治療市場競爭格局
  • 夥伴關係/合作/協議
  • 合併與收購
  • 新產品上市
  • 其他發展

第10章: 公司概況

  • 頂級公司市場佔有率分析
  • 市場集中度
  • Mayo Clinic
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Johns Hopkins Hospital
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Cleveland Clinic
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Great Ormond Street Hospital
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Apollo Hospitals
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Tokyo Medical University Hospital
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • The Prince Charles Hospital
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Helios Hospital
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Aster Hospitals
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Other
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展

注-在公司概況中,財務細節和近期發展視情況而定,如果是私營公司則可能不包括在內。

Product Code: VMR112110671

The global demand for Acute Lung Injury Treatment Market is presumed to reach the market size of nearly USD 9.27 BN by 2030 from USD 6.22 BN in 2022 with a CAGR of 5.12% under the study period 2022 - 2030.

Acute Lung Injury (ALI) is a condition in which the lungs become severely inflamed, leading to fluid accumulation in the lungs and impaired gas exchange. ALI is a medical emergency that requires immediate treatment. The treatment of ALI is aimed at managing the underlying cause of the condition and providing supportive care to improve lung function and oxygenation. The treatment of ALI is complex, and the approach may vary depending on the severity of the condition and the underlying cause. Close monitoring and management of ALI are crucial to improve outcomes and prevent complications.

Market Dynamics:

The rising prevalence of ALI, especially among critically ill patients, is a major driver of the ALI treatment market. The increasing incidence of ALI is primarily due to the aging population, increased prevalence of chronic diseases, and higher rates of hospitalization. Technological advancements have significantly improved the diagnosis and treatment of ALI. The new therapeutic agents development, such as anti-inflammatory drugs and immunomodulatory agents, has led to more effective and targeted treatments for ALI. Governments and regulatory bodies worldwide are investing heavily in the development of new treatments for ALI. This funding is driving research and development efforts in the field, leading to the development of new and innovative therapies.Healthcare professionals are becoming more aware of the potential risks and consequences of ALI, leading to earlier diagnosis and treatment. This awareness is driving the demand for ALI treatment. The demand for non-invasive ventilation techniques, such as continuous positive and bi-level positive airway pressure is increasing. These techniques are preferred over invasive mechanical ventilation, which can cause complications such as infections and lung injury. Growing focus on personalized medicine: Personalized medicine is gaining popularity in the ALI treatment market. This approach involves tailoring treatments to the individual patient, taking into account their genetic makeup, medical history, and other factors. Personalized medicine is expected to lead to more effective and targeted treatments for ALI.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of acute lung injury treatment. The growth and trends of acute lung injury treatment industry provide a holistic approach to this study.

Market Segmentation:

This section of the acute lung injury treatment market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Therapy

  • Mechanical Ventilation
  • Pharmacotherapy
  • Fluid Management
  • Others

By End-User

  • Hospitals
  • Specialty Centers
  • Others

Regional Analysis

This section covers the regional outlook, which accentuates current and future demand for the Acute Lung Injury Treatment market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the acute lung injury treatment market include Mayo Clinic, Johns Hopkins Hospital, Cleveland Clinic, Great Ormond Street Hospital, Apollo Hospitals, Tokyo Medical University Hospital, The Prince Charles Hospital, Helios Hospital, Aster Hospitals, Other. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . ACUTE LUNG INJURY TREATMENT - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Therapy
    • 3.7.2 Market Attractiveness Analysis By End-User
    • 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL ACUTE LUNG INJURY TREATMENT MARKET ANALYSIS BY THERAPY

  • 6.1 Overview by Therapy
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Therapy
  • 6.4 Mechanical Ventilation Historic and Forecast Sales by Regions
  • 6.5 Pharmacotherapy Historic and Forecast Sales by Regions
  • 6.6 Fluid Management Historic and Forecast Sales by Regions
  • 6.7 Others Historic and Forecast Sales by Regions

7 . GLOBAL ACUTE LUNG INJURY TREATMENT MARKET ANALYSIS BY END-USER

  • 7.1 Overview by End-User
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by End-User
  • 7.4 Hospitals Historic and Forecast Sales by Regions
  • 7.5 Specialty Centers Historic and Forecast Sales by Regions
  • 7.6 Others Historic and Forecast Sales by Regions

8 . GLOBAL ACUTE LUNG INJURY TREATMENT MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1. Overview, Historic and Forecast Sales Analysis
    • 8.3.2. North America By Segment Sales Analysis
    • 8.3.3. North America By Country Sales Analysis
    • 8.3.4. United State Sales Analysis
    • 8.3.5. Canada Sales Analysis
    • 8.3.6. Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1. Overview, Historic and Forecast Sales Analysis
    • 8.4.2. Europe by Segment Sales Analysis
    • 8.4.3. Europe by Country Sales Analysis
    • 8.4.4. United Kingdom Sales Analysis
    • 8.4.5. France Sales Analysis
    • 8.4.6. Germany Sales Analysis
    • 8.4.7. Italy Sales Analysis
    • 8.4.8. Russia Sales Analysis
    • 8.4.9. Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1. Overview, Historic and Forecast Sales Analysis
    • 8.5.2. Asia Pacific by Segment Sales Analysis
    • 8.5.3. Asia Pacific by Country Sales Analysis
    • 8.5.4. China Sales Analysis
    • 8.5.5. India Sales Analysis
    • 8.5.6. Japan Sales Analysis
    • 8.5.7. South Korea Sales Analysis
    • 8.5.8. Australia Sales Analysis
    • 8.5.9. Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1. Overview, Historic and Forecast Sales Analysis
    • 8.6.2. Latin America by Segment Sales Analysis
    • 8.6.3. Latin America by Country Sales Analysis
    • 8.6.4. Brazil Sales Analysis
    • 8.6.5. Argentina Sales Analysis
    • 8.6.6. Peru Sales Analysis
    • 8.6.7. Chile Sales Analysis
    • 8.6.8. Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1. Overview, Historic and Forecast Sales Analysis
    • 8.7.2. Middle East & Africa by Segment Sales Analysis
    • 8.7.3. Middle East & Africa by Country Sales Analysis
    • 8.7.4. Saudi Arabia Sales Analysis
    • 8.7.5. UAE Sales Analysis
    • 8.7.6. Israel Sales Analysis
    • 8.7.7. South Africa Sales Analysis
    • 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE ACUTE LUNG INJURY TREATMENT COMPANIES

  • 9.1. Acute Lung Injury Treatment Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10 . COMPANY PROFILES OF ACUTE LUNG INJURY TREATMENT INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Mayo Clinic
    • 10.3.1. Company Overview
    • 10.3.2. Company Revenue
    • 10.3.3. Products
    • 10.3.4. Recent Developments
  • 10.4. Johns Hopkins Hospital
    • 10.4.1. Company Overview
    • 10.4.2. Company Revenue
    • 10.4.3. Products
    • 10.4.4. Recent Developments
  • 10.5. Cleveland Clinic
    • 10.5.1. Company Overview
    • 10.5.2. Company Revenue
    • 10.5.3. Products
    • 10.5.4. Recent Developments
  • 10.6. Great Ormond Street Hospital
    • 10.6.1. Company Overview
    • 10.6.2. Company Revenue
    • 10.6.3. Products
    • 10.6.4. Recent Developments
  • 10.7. Apollo Hospitals
    • 10.7.1. Company Overview
    • 10.7.2. Company Revenue
    • 10.7.3. Products
    • 10.7.4. Recent Developments
  • 10.8. Tokyo Medical University Hospital
    • 10.8.1. Company Overview
    • 10.8.2. Company Revenue
    • 10.8.3. Products
    • 10.8.4. Recent Developments
  • 10.9. The Prince Charles Hospital
    • 10.9.1. Company Overview
    • 10.9.2. Company Revenue
    • 10.9.3. Products
    • 10.9.4. Recent Developments
  • 10.10. Helios Hospital
    • 10.10.1. Company Overview
    • 10.10.2. Company Revenue
    • 10.10.3. Products
    • 10.10.4. Recent Developments
  • 10.11. Aster Hospitals
    • 10.11.1. Company Overview
    • 10.11.2. Company Revenue
    • 10.11.3. Products
    • 10.11.4. Recent Developments
  • 10.12. Other
    • 10.12.1. Company Overview
    • 10.12.2. Company Revenue
    • 10.12.3. Products
    • 10.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Therapy (USD MN)
  • Mechanical Ventilation Market Sales by Geography (USD MN)
  • Pharmacotherapy Market Sales by Geography (USD MN)
  • Fluid Management Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis Market by End-User (USD MN)
  • Hospitals Market Sales by Geography (USD MN)
  • Specialty Centers Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Acute Lung Injury Treatment Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Acute Lung Injury Treatment Report
  • Market Research Process
  • Market Research Methodology
  • Global Acute Lung Injury Treatment Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Therapy
  • Market Attractiveness Analysis by End-User
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Therapy (USD MN)
  • Mechanical Ventilation Market Sales by Geography (USD MN)
  • Pharmacotherapy Market Sales by Geography (USD MN)
  • Fluid Management Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by End-User (USD MN)
  • Hospitals Market Sales by Geography (USD MN)
  • Specialty Centers Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Top Companies Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.